ANNE WALTON: Open Payments
NPI 1891386561 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,665 in 169 payments from 16 companies in 2025. Trend: 2023 $1,805 · 2024 $2,278 · 2025 $2,665
Food & beverage: $2,588Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $694 |
| Janssen Biotech, Inc. | 21 | $454 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $263 |
| Ipsen Biopharmaceuticals, Inc | 11 | $228 |
| Ardelyx, Inc. | 9 | $182 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $140 |
| Madrigal Pharmaceuticals | 12 | $139 |
| Phathom Pharmaceuticals, Inc. | 11 | $107 |
| Gilead Sciences, Inc. | 4 | $96 |
| QOL Medical, LLC | 4 | $95 |
Products named: TREMFYA, ENTYVIO, RINVOQ, IQIRVO, SKYRIZI, IBSRELA, REZDIFFRA, CREON.
Industry payments across LA — which companies pay providers there.
